Amelie Pielen Selected Research

N-acetyltryptophanamide (NATA)

1/2020

Ranibizumab Pro Re nata versus Dexamethasone in the Management of Ischemic Retinal Vein Occlusion: Post-hoc Analysis from the COMRADE Trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amelie Pielen Research Topics

Disease

16	Retinal Vein Occlusion 01/2020 - 02/2011
10	Macular Edema 12/2021 - 02/2011
4	Glaucoma 01/2020 - 01/2015
4	Macular Degeneration (Age-Related Maculopathy) 01/2017 - 10/2015
2	Central Serous Chorioretinopathy 03/2022 - 06/2021
2	Retinal Perforations 12/2020 - 09/2014
2	Retinal Detachment (Retinal Detachments) 12/2020 - 01/2017
2	Diabetes Mellitus 03/2017 - 12/2016
1	Edema (Dropsy) 03/2022
1	Retinoschisis (Retinoschisis, Juvenile) 12/2020
1	Ischemia 01/2020
1	Diabetic Angiopathies (Diabetic Angiopathy) 01/2019
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2019
1	Hypertension (High Blood Pressure) 03/2017
1	Relapsing-Remitting Multiple Sclerosis 12/2016
1	Optic Neuritis (Retrobulbar Neuritis) 03/2016
1	Choroidal Neovascularization 01/2016
1	Cysts 01/2016
1	Retinal Artery Occlusion 10/2015
1	Cicatrix (Scar) 10/2015
1	Fibrosis (Cirrhosis) 10/2015
1	Corneal Injuries 10/2015
1	Inflammation (Inflammations) 01/2015
1	Papilledema 01/2015
1	Hypoxia (Hypoxemia) 01/2015
1	Epiretinal Membrane (Epiretinal Membranes) 09/2014
1	Pathologic Neovascularization 06/2013
1	Cataract (Cataracts) 01/2013
1	Optic Nerve Diseases (Optic Neuropathy) 03/2005

Drug/Important Bio-Agent (IBA)

9	Retinaldehyde (Retinal)IBA 01/2020 - 03/2005
8	Ranibizumab (Lucentis)FDA Link 01/2020 - 01/2015
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 09/2016
5	Bevacizumab (Avastin)FDA Link 03/2017 - 02/2011
5	afliberceptIBA 01/2017 - 10/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 08/2011
1	Fluorescein (Funduscein)FDA LinkGeneric 06/2021
1	N-acetyltryptophanamide (NATA)IBA 01/2020
1	Macular PigmentIBA 01/2020
1	ElementsIBA 03/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	CholesterolIBA 01/2019
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2019
1	Endothelial Growth FactorsIBA 01/2017
1	Fingolimod Hydrochloride (FTY720)FDA Link 12/2016
1	Erythropoietin FDA Link 03/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2015
1	MicroRNAs (MicroRNA)IBA 10/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	N 30IBA 01/2015
1	Semaphorins (Semaphorin)IBA 06/2013
1	SteroidsIBA 01/2013
1	Peptides (Polypeptides)IBA 03/2005

Therapy/Procedure

9	Therapeutics 06/2021 - 02/2011
4	Lasers (Laser) 03/2022 - 01/2013
3	Vitrectomy 12/2020 - 09/2014
2	Intravitreal Injections 12/2021 - 01/2015
2	Injections 03/2017 - 01/2017
2	Light Coagulation 02/2015 - 01/2013
1	Laser Therapy (Surgery, Laser) 01/2020
1	Conservative Treatment 10/2015
1	Hemodilution 01/2015